- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$184.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$59,525.00
7D
2.1%
1Y
53.6%
Bristol-Myers Squibb
Market Cap: US$138.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.07
7D
-2.5%
1Y
47.4%
Bristol-Myers Squibb
Market Cap: AR$138.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$36,220.00
7D
2.0%
1Y
67.9%
Bayer
Market Cap: AR$48.2b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$30,120.00
7D
-3.1%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.05
7D
2.2%
1Y
n/a
GSK
Market Cap: US$76.1b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.50
7D
-0.3%
1Y
36.1%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,860.00
7D
3.3%
1Y
n/a
GSK
Market Cap: AR$76.1b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,650.00
7D
-1.2%
1Y
53.0%
Gilead Sciences
Market Cap: US$184.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$37.99
7D
0.4%
1Y
31.0%
Amgen
Market Cap: US$239.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$15.30
7D
-0.6%
1Y
60.2%
AstraZeneca
Market Cap: AR$189.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$66,850.00
7D
2.6%
1Y
23.5%
Biogen
Market Cap: AR$32.6b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$27,380.00
7D
1.9%
1Y
92.5%
Amgen
Market Cap: AR$239.1b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$23,560.00
7D
1.0%
1Y
81.6%
Vertex Pharmaceuticals
Market Cap: AR$140.1b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,720.00
7D
0.8%
1Y
67.7%
Biogen
Market Cap: US$32.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.65
7D
2.0%
1Y
68.1%
Novartis
Market Cap: US$243.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$41.01
7D
0.2%
1Y
28.6%
Novartis
Market Cap: AR$241.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$63,275.00
7D
-0.1%
1Y
46.6%
Vertex Pharmaceuticals
Market Cap: US$138.7b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.66
7D
0.7%
1Y
38.6%
AstraZeneca
Market Cap: US$189.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$42.94
7D
0.8%
1Y
7.5%